INAFM2
Putative transmembrane protein INAFM2
Also known as: INAM2_HUMAN, LINC00984, OGU1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DMQ5
- Gene
- INAFM2
- Ensembl
- ENSG00000259330
- Chromosome
- 15
- Canonical length
- 153 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>P0DMQ5|INAFM2
1 MKERDAAPAE RGKPATYTGD KKAKMAAKTN KKWVRLATVF AYVLSVSLAA IVLAVYYSLI
61 WQPVGAGTSG GAAGPPPGGS NATGPSGTSG AAAAGPNTTG SSRREAPRDV PPLQAARPAP
121 PEPPADSPPA GPLERPRGPD EDEEETAAAP GSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against INAFM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- colon: 47 nTPM
- blood vessel: 45 nTPM
- heart muscle: 27 nTPM
- stomach: 27 nTPM
- fallopian tube: 25 nTPM
- thyroid gland: 25 nTPM
Single-cell type
- platelets: 385 nCPM
- megakaryocytes: 93 nCPM
- late primary spermatocytes: 69 nCPM
- hofbauer cells: 36 nCPM
- smooth muscle cells: 35 nCPM
- megakaryocyte progenitors: 32 nCPM
Immune cell
- eosinophil: 2.7 nTPM
- intermediate monocyte: 1.1 nTPM
- plasmacytoid DC: 1.1 nTPM
- classical monocyte: 1 nTPM
- non-classical monocyte: 1 nTPM
- neutrophil: 0.7 nTPM
Brain region
- white matter: 33 nTPM
- medulla oblongata: 27 nTPM
- cerebral cortex: 25 nTPM
- hypothalamus: 25 nTPM
- spinal cord: 25 nTPM
- basal ganglia: 23 nTPM
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads INAFM2 as an antibody target. Whether an autoantibody or antibody against INAFM2 could matter depends on whether native INAFM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
INAFM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label INAFM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...